Novo Nordisk (NVO +2.31%) stock is underperforming in 2025, and investors are interested in buying this stock on the dip.
*Stock prices used were the afternoon prices of Nov. 16, 2025. The video was published on Nov. 18, 2025.
Should Investors Buy Novo Nordisk Stock Near Its Near 52-Week Low?
By Parkev Tatevosian, CFA – Nov 19, 2025 at 11:36AM
NYSE: NVO
Novo Nordisk
Market Cap
$160B
Today's Change
(2.31%) $1.10
Current Price
$48.65
Price as of November 19, 2025 at 12:46 PM ET
Novo Nordisk is investing aggressively to improve its pipeline of drugs in development.
About the Author
A Fool since 2019, and a graduate of Cal State LA with a B.S. in Finance and M.A. in Economics. Parkev is an adjunct professor of Finance and enjoys reading about financial and economic history. You'll often find him writing about stocks in the consumer goods and technology sectors.